• 1. Polypeptides. Part XIII. The use of β-methylthioethyl esters for the protection of carboxyl groups in peptide synthesis
  M. Joaquina S. A. Amaral,G. C. Barrett,H. N. Rydon,J. E. Willett J. Chem. Soc. C 1966 807
• 2. Naturally occurring isocyanides
  M. S. Edenborough,R. B. Herbert Nat. Prod. Rep. 1988 5 229
• 3. Naturally occurring isocyanides
  M. S. Edenborough,R. B. Herbert Nat. Prod. Rep. 1988 5 229
• 4. 89. The stereochemical relationships of some optically active amines and amino-acids. Part I. The configuration of valine
  Fred Barrow,George W. Ferguson J. Chem. Soc. 1935 410

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to Valine, N-formyl- (CAS No. 4289-96-7)

Valine, N-formyl- (CAS No. 4289-96-7) is a key intermediate in the field of pharmaceutical chemistry and biochemistry. This compound, characterized by its N-formyl functional group, plays a significant role in various biochemical pathways and synthetic applications. The molecular structure of Valine, N-formyl- consists of an amino acid backbone with a formyl group attached to the nitrogen atom, making it a versatile building block for more complex molecules.

The CAS number 4289-96-7 is a unique identifier that ensures precise classification and recognition within the chemical industry. This compound is primarily utilized in the synthesis of peptides, amino acid derivatives, and other pharmacologically active agents. Its structural properties make it particularly valuable in the development of drugs targeting neurological disorders, infectious diseases, and metabolic conditions.

Recent advancements in the field of medicinal chemistry have highlighted the importance of Valine, N-formyl- in drug design. Researchers have discovered that the formyl group can enhance the bioavailability and binding affinity of therapeutic compounds. This has led to increased interest in exploring its applications in targeted drug delivery systems and prodrug formulations.

In the realm of academic research, studies have demonstrated that Valine, N-formyl- can serve as a precursor for the synthesis of bioactive peptides. These peptides have shown promise in treating conditions such as cancer, inflammation, and autoimmune diseases. The ability to modify the formyl group allows for fine-tuning of peptide properties, enabling researchers to develop highly specific therapeutic agents.

The pharmaceutical industry has also leveraged Valine, N-formyl- in the development of antimicrobial agents. Its structural features contribute to the efficacy of compounds designed to combat resistant bacterial strains. By incorporating this intermediate into drug molecules, scientists have been able to create novel antibiotics with improved pharmacokinetic profiles.

Another area where Valine, N-formyl- has made significant contributions is in the field of enzyme inhibition. Researchers have utilized this compound to develop inhibitors targeting key enzymes involved in metabolic pathways. These inhibitors have potential applications in treating metabolic disorders such as diabetes and obesity. The formyl group's ability to interact with enzyme active sites has been crucial in designing highly effective inhibitors.

Furthermore, Valine, N-formyl- has been explored in the development of neuroprotective agents. Studies suggest that compounds derived from this intermediate can protect against neurodegenerative diseases by modulating neuronal signaling pathways. The formyl group's role in enhancing molecular interactions has been instrumental in developing drugs that target neuroinflammatory processes.

The synthesis of Valine, N-formyl- involves sophisticated chemical methodologies that ensure high purity and yield. Advanced techniques such as formylation reactions and peptide coupling methods are employed to produce this compound with minimal impurities. These synthetic strategies are critical for ensuring the efficacy and safety of pharmaceutical products derived from this intermediate.

In conclusion, Valine, N-formyl- (CAS No. 4289-96-7) is a multifaceted compound with extensive applications in pharmaceutical research and development. Its unique structural properties make it an invaluable tool for synthesizing bioactive molecules targeting various diseases. As research continues to uncover new therapeutic possibilities, the significance of this compound is expected to grow further.

• 2566-32-7(N-Methyl-dl-valine Hydrochloride)
• 2480-23-1(N-Methyl-L-valine)
• 17916-88-0(N-Acetyl-D-valine)
• 106873-99-8(2-Formamidobutanoic acid)
• 4289-97-8(N-Formyl-L-valine)
• 82413-57-8(2-(Formylamino)butanoic acid)
• 96-81-1(N-Acetyl-L-valine)
• 88930-14-7(N-Methyl-D-valine)
• 6113-61-7(N-Formyl-L-leucine)
• 3067-19-4(N-Acetyl-DL-Valine)